Sirona Biochem (TSE:SBM) has released an update.
Sirona Biochem Corp. partners with Stonegate Healthcare Partners to boost business development and investor relations, focusing on their innovative anti-aging ingredient, GlycoProteMim. The collaboration aims to tap into Stonegate’s vast network and expertise to enhance GlycoProteMim’s market presence in the skincare industry. This strategic partnership is expected to elevate Sirona’s global reach and accelerate the commercialization of their proprietary anti-aging solutions.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com